Egyptian Drug Authority Signs New Agreement to Enhance Professional Training in the Medical Sector
The fifth edition of the Africa Health ExCon 2026 witnessed a significant step toward supporting the health sector in Egypt. The Egyptian Drug Authority signed a new cooperation protocol with GlaxoSmithKline Egypt, aimed at developing human resources working in the pharmaceutical field.
This collaboration aims to enhance training and professional development programs for pharmacists and those working in the pharmaceutical sector. Through this partnership, the Authority seeks to increase the efficiency of workers and equip them with the latest knowledge and skills necessary to keep pace with global developments in the pharmaceutical industry.
This agreement is part of the Egyptian state's strategy to develop the healthcare system, as it focuses on exchanging expertise with leading global companies. It is expected that this training will contribute to improving the quality of pharmaceutical services provided to citizens across the Republic.
This event comes at a time when Egypt is placing great importance on strengthening its position as a regional hub for medical industries in Africa. The Africa Health ExCon annually brings together experts and specialists from various countries to discuss ways to cooperate and develop healthcare on the continent.
At the conclusion of the events, officials emphasized that these partnerships represent a fundamental pillar for achieving Egypt's Vision 2030 in the field of health. The Authority continues its efforts to conclude further agreements that ensure the provision of safe and effective medicine for the Egyptian community.